Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Key Market Players: Glucagon-like Peptide-1 (GLP-1) Agonists Market Leaders Novo Nordisk Eli Lilly and Company AstraZeneca Sanofi Pfizer
In endothelial cell models, BPC-157 significantly enhanced ERK1/2 phosphorylation in a dose-dependent manner, leading to increased cellular proliferation, migration, and vascular tube formation mediated through downstream activation of transcription factors c-Fos, c-Jun, and EGR-1
Does PlexusDx screen for contraindications before prescribing
Stability varies by peptide consult a Certificate of Analysis or peer-reviewed reference for your specific compound
US$ 20.28
US$ 23.02
US$ 26.59
US$ 21.68
US$ 22.79
US$ 20.68
